{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:07:15Z","timestamp":1792296435573,"version":"4.4.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711080"],"award-info":[{"award-number":["2022M711080"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013318","name":"Shanxi Provincial Science and Technology Department","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.intimp.2024.113696","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:52:07Z","timestamp":1732683127000},"page":"113696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Preventing NLRP3 inflammasome activation: Therapeutic atrategy and challenges in atopic dermatitis"],"prefix":"10.1016","volume":"144","author":[{"given":"Yiran","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiran","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsheng","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quekun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10023","key":"10.1016\/j.intimp.2024.113696_b0005","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.intimp.2024.113696_b0010","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra2023911","article-title":"Atopic dermatitis","volume":"384","author":"Stander","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082867","article-title":"Skin barrier abnormalities and immune dysfunction in atopic dermatitis","volume":"21","author":"Yang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","article-title":"Update on the pathogenesis and therapy of atopic dermatitis","volume":"61","author":"Li","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0025","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1164\/rccm.202110-2418OC","article-title":"Evolution of eczema, wheeze, and rhinitis from infancy to early adulthood: four birth cohort studies","volume":"206","author":"Haider","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0030","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jaad.2018.08.063","article-title":"Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis","volume":"80","author":"Patel","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/bjd.16891","article-title":"Revisiting atopic dermatitis and cardiovascular disease","volume":"179","author":"Drucker","year":"2018","journal-title":"Br. J. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0040","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/all.13401","article-title":"Epidemiology of atopic dermatitis in adults: results from an international survey","volume":"73","author":"Barbarot","year":"2018","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jid.2016.07.012","article-title":"The burden of atopic dermatitis: summary of a report for the national eczema association","volume":"137","author":"Drucker","year":"2017","journal-title":"J, Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0050","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jdermsci.2021.04.007","article-title":"Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents","volume":"102","author":"Luger","year":"2021","journal-title":"J. Dermatol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0055","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based european guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part i","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0060","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2022.12.002","article-title":"Comorbidities of atopic dermatitis-what does the evidence say?","volume":"151","author":"Thyssen","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0065","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","article-title":"Progressive activation of t(h)2\/t(h)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis","volume":"130","author":"Gittler","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.anai.2023.11.020","article-title":"Diversity of atopic dermatitis and selection of immune targets","volume":"132","author":"Rothenberg-Lausell","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","article-title":"Atopic dermatitis: immune deviation, barrier dysfunction, ige autoreactivity and new therapies","volume":"66","author":"Furue","year":"2017","journal-title":"Allergol. Int."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0080","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2010.08.013","article-title":"Significant correlation of serum il-22 levels with ccl17 levels in atopic dermatitis","volume":"61","author":"Hayashida","year":"2011","journal-title":"J. Dermatol. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0085","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.jaci.2015.05.049","article-title":"Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (cla)(+) th2\/th1 cell imbalance, whereas adults acquire cla(+) th22\/tc22 cell subsets","volume":"136","author":"Czarnowicki","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113696_b0090","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm.3893","article-title":"Inflammasomes: mechanism of action, role in disease, and therapeutics","volume":"21","author":"Guo","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41392-021-00650-z","article-title":"Inflammasomes as therapeutic targets in human diseases","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2024.113696_b0100","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrd.2018.149","article-title":"Targeting the nlrp3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jdermsci.2019.08.006","article-title":"Interleukin-33 in atopic dermatitis","volume":"96","author":"Imai","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.intimp.2024.113696_b0110","article-title":"Interleukin-18 and il-18bp in inflammatory dermatological diseases","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2024.113696_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116344","article-title":"A homogeneous lonicera japonica polysaccharide alleviates atopic dermatitis by promoting nrf2 activation and nlrp3 inflammasome degradation via p62","volume":"309","author":"Bai","year":"2023","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","article-title":"Drugging the nlrp3 inflammasome: from signalling mechanisms to therapeutic targets","volume":"23","author":"Vande","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.intimp.2024.113696_b0125","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41419-021-04420-1","article-title":"Identification of an asc oligomerization inhibitor for the treatment of inflammatory diseases","volume":"12","author":"Soriano-Teruel","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0130","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 american academy of allergy, asthma and immunology\/american college of allergy, asthma and immunology joint task force on practice parameters grade- and institute of medicine-based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0952-7915(95)80050-6","article-title":"The th1\/th2 balance in autoimmunity","volume":"7","author":"Charlton","year":"1995","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0145","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1471-4906(03)00067-X","article-title":"Novel il-12 family members shed light on the orchestration of th1 responses","volume":"24","author":"Brombacher","year":"2003","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaci.2022.06.012","article-title":"Modulation of il-4\/il-13 cytokine signaling in the context of allergic disease","volume":"150","author":"Shankar","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/imr.13230","article-title":"Engineering the il-4\/il-13 axis for targeted immune modulation","volume":"320","author":"Bernstein","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.intimp.2024.113696_b0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-94-017-9487-9_2","article-title":"Th1\/th2 cell differentiation and molecular signals","volume":"841","author":"Zhang","year":"2014","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0165","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/all.12184","article-title":"Immunology of atopic eczema: overcoming the th1\/th2 paradigm","volume":"68","author":"Eyerich","year":"2013","journal-title":"Allergy"},{"issue":"55","key":"10.1016\/j.intimp.2024.113696_b0170","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abe2749","article-title":"Persistence of mature dendritic cells, t(h)2a, and tc2 cells characterize clinically resolved atopic dermatitis under il-4ralpha blockade","volume":"6","author":"Bangert","year":"2021","journal-title":"Sci. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2024.113696_b0175","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/all.14196","article-title":"Tslp and il-33 reciprocally promote each other's lung protein expression and ilc2 receptor expression to enhance innate type-2 airway inflammation","volume":"75","author":"Toki","year":"2020","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.intimp.2024.113696_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9113741","article-title":"Regulation of skin barrier function via competition between ahr axis versus il-13\/il-4\u2013jak\u2013stat6\/stat3 axis: pathogenic and therapeutic implications in atopic dermatitis","volume":"9","author":"Furue","year":"2020","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0923-1811(02)00149-4","article-title":"Both il-4 and il-13 inhibit the tnf-alpha and ifn-gamma enhanced mdc production in a human keratinocyte cell line, hacat cells","volume":"31","author":"Xiao","year":"2003","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100066","article-title":"Identification of keratinocyte mitogens: implications for hyperproliferation in psoriasis and atopic dermatitis","volume":"2","author":"Niehues","year":"2022","journal-title":"Jid Innov"},{"key":"10.1016\/j.intimp.2024.113696_b0195","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","article-title":"Atopic dermatitis: pathophysiology","volume":"1027","author":"David","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.intimp.2024.113696_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154200","article-title":"Therapeutic effects of myricetin on atopic dermatitis in vivo and in vitro","volume":"102","author":"Hou","year":"2022","journal-title":"Phytomedicine"},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21082693","article-title":"Nasal epithelial cells activated with alternaria and house dust mite induce not only th2 but also th1 immune responses","volume":"21","author":"Shin","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-018-8685-0","article-title":"The unique molecular signatures of contact dermatitis and implications for treatment","volume":"56","author":"Leonard","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.intimp.2024.113696_b0215","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s11655-022-3579-7","article-title":"Acupoint autohemotherapy attenuates atopic dermatitis lesions by regulating th1\/th2 balance in dncb-induced balb\/c mice","volume":"28","author":"Zeng","year":"2022","journal-title":"Chin. J. Integr. Med."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0220","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2011.05.043","article-title":"Reduced ifn-gamma receptor expression and attenuated ifn-gamma response by dendritic cells in patients with atopic dermatitis","volume":"128","author":"Gros","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0225","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jaci.2009.03.041","article-title":"Il-22-producing \u201ct22\u201d t cells account for upregulated il-22 in atopic dermatitis despite reduced il-17-producing th17 t cells","volume":"123","author":"Nograles","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113696_b0230","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jid.2016.05.117","article-title":"Early activation of th2\/th22 inflammatory and pruritogenic pathways in acute canine atopic dermatitis skin lesions","volume":"136","author":"Olivry","year":"2016","journal-title":"J, Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0235","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.jaci.2020.08.041","article-title":"Mild atopic dermatitis lacks systemic inflammation and shows reduced nonlesional skin abnormalities","volume":"147","author":"He","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/all.15816","article-title":"Cla+ memory t cells in atopic dermatitis: cla+ t cells and atopic dermatitis","volume":"79","author":"Nicolas","year":"2024","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0245","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/s41467-023-38209-x","article-title":"Hydrogel dressing integrating fak inhibition and ros scavenging for mechano-chemical treatment of atopic dermatitis","volume":"14","author":"Jia","year":"2023","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0250","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/exd.13854","article-title":"Ultraviolet radiation, both uva and uvb, influences the composition of the skin microbiome","volume":"28","author":"Burns","year":"2019","journal-title":"Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0255","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/ijd.14016","article-title":"Climate change and atopic dermatitis: is there a link?","volume":"58","author":"Nguyen","year":"2019","journal-title":"Int. J. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0260","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jaip.2021.10.060","article-title":"Efficacy of house dust mite sublingual immunotherapy in patients with atopic dermatitis: a randomized, double-blind, placebo-controlled trial","volume":"10","author":"Langer","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0265","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1159\/000522525","article-title":"Microarray analysis confirms immunocap-fluorescence enzyme immunoassay results on specific ige in patients with atopic dermatitis and suspected birch pollen-related food allergy","volume":"183","author":"Wassmann-Otto","year":"2022","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0270","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor mavs promotes nlrp3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0275","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","article-title":"Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial","volume":"27","author":"Nakatsuji","year":"2021","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0280","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jamadermatol.2017.3647","article-title":"Effect of oral administration of a mixture of probiotic strains on scorad index and use of topical steroids in young patients with moderate atopic dermatitis: a randomized clinical trial","volume":"154","author":"Navarro-Lopez","year":"2018","journal-title":"JAMA Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0285","article-title":"Pruritus as a distinctive feature of type 2 inflammation","volume":"9","author":"Garcovich","year":"2021","journal-title":"Vaccines (basel)"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0295","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.cell.2020.12.033","article-title":"A basophil-neuronal axis promotes itch","volume":"184","author":"Wang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.intimp.2024.113696_b0300","doi-asserted-by":"crossref","first-page":"1037925","DOI":"10.3389\/fphar.2023.1037925","article-title":"Trpv1: a promising therapeutic target for skin aging and inflammatory skin diseases","volume":"14","author":"Xiao","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0305","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/jdv.15973","article-title":"Neuroimmune interactions in chronic itch of atopic dermatitis","volume":"34","author":"Yosipovitch","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113696_b0310","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.it.2018.10.001","article-title":"The itch-scratch cycle: a neuroimmune perspective","volume":"39","author":"Mack","year":"2018","journal-title":"Trends Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0315","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bjd.17114","article-title":"How acute stress impacts the itch-scratch cycle in atopic dermatitis: a clinical lesson","volume":"180","author":"Stander","year":"2019","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0320","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1468-3083.2011.04133.x","article-title":"The effect of topically applied corticosteroids on interleukin 1beta levels in patients with atopic dermatitis","volume":"26","author":"Nutan","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0325","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jaci.2017.12.991","article-title":"Serum biomarker profiles suggest that atopic dermatitis is a systemic disease","volume":"141","author":"Thijs","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0330","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jaci.2011.12.989","article-title":"Filaggrin loss-of-function mutations are associated with enhanced expression of il-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency","volume":"129","author":"Kezic","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0335","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00403-011-1198-9","article-title":"Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis","volume":"304","author":"Kou","year":"2012","journal-title":"Arch. Dermatol. Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.113696_b0340","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/j.1365-2230.2011.04113.x","article-title":"Relationship between serum levels of interleukin-18, ige and disease severity in patients with atopic dermatitis","volume":"36","author":"Trzeciak","year":"2011","journal-title":"Clin. Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0345","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/all.15153","article-title":"Assessment of biomarkers in pediatric atopic dermatitis by tape strips and skin biopsies","volume":"77","author":"Andersson","year":"2022","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0350","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.anai.2020.08.397","article-title":"Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin","volume":"126","author":"Lyubchenko","year":"2021","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0355","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jdermsci.2010.05.004","article-title":"Granzyme b is a novel interleukin-18 converting enzyme","volume":"59","author":"Omoto","year":"2010","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0360","first-page":"560","article-title":"Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with staphylococcus aureus colonization","volume":"164","author":"Inoue","year":"2011","journal-title":"Br. J. Dermatol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0365","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22084130","article-title":"Molecular mechanisms of atopic dermatitis pathogenesis","volume":"22","author":"Sroka-Tomaszewska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113696_b0370","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both th1 and th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0375","doi-asserted-by":"crossref","first-page":"880","DOI":"10.3892\/ijmm.2020.4630","article-title":"Il\u201118 knockout alleviates atopic dermatitis\u2011like skin lesions induced by mc903 in a mouse model","volume":"46","author":"Chen","year":"2020","journal-title":"Int. J. Mol. Med."},{"issue":"Pt B","key":"10.1016\/j.intimp.2024.113696_b0380","article-title":"Inhibition of gasdermin d (gsdmd) as a promising therapeutic approach for atopic dermatitis","volume":"124","author":"Lu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2024.113696_b0385","doi-asserted-by":"crossref","first-page":"e16768","DOI":"10.7717\/peerj.16768","article-title":"Gsdmd suppresses keratinocyte differentiation by inhibiting flg expression and attenuating kctd6-mediated hdac1 degradation in atopic dermatitis","volume":"12","author":"Zhong","year":"2024","journal-title":"PeerJ"},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0390","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/eji.200636465","article-title":"Il-18 time-dependently modulates th1\/th2 cytokine production by ligand-activated nkt cells","volume":"37","author":"Uchida","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2024.113696_b0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000323302","article-title":"Contribution of interleukin 18 to the development of infection-associated atopic dermatitis","volume":"41","author":"Tsutsui","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0400","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nri3452","article-title":"Activation and regulation of the inflammasomes","volume":"13","author":"Latz","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2024.113696_b0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117490","article-title":"Xiaoqinglong decoction improves allergic rhinitis by inhibiting nlrp3-mediated pyroptosis in balb\/c mice","volume":"321","author":"Wang","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0410","doi-asserted-by":"crossref","first-page":"e236122","DOI":"10.1128\/mbio.02361-22","article-title":"Inflammasome activation dampens type i ifn signaling to strengthen anti-toxoplasma immunity","volume":"13","author":"Hu","year":"2022","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0415","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s41467-023-36323-4","article-title":"Microbiota-derived acetate enhances host antiviral response via nlrp3","volume":"14","author":"Niu","year":"2023","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0420","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/1440-1681.13306","article-title":"Atractylenolide iii reduces nlrp3 inflammasome activation and th1\/th2 imbalances in both in vitro and in vivo models of asthma","volume":"47","author":"Zhu","year":"2020","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0425","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/exd.14432","article-title":"Nlrp3 inflammasome activation contributes to development of alopecia areata in c3h\/hej mice","volume":"31","author":"Hashimoto","year":"2022","journal-title":"Exp. Dermatol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0430","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12011-023-03715-y","article-title":"Dietary zinc ameliorates tnbs-induced colitis in mice associated with regulation of th1\/th2\/th17 balance and nf-kappab\/nlrp3 signaling pathway","volume":"202","author":"Wen","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.intimp.2024.113696_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104659","article-title":"Pharmacological suppression of nlrp3 inflammasome attenuated the development of autoimmune thyroiditis","volume":"384","author":"Ding","year":"2023","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.intimp.2024.113696_b0440","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.canlet.2021.06.014","article-title":"Nlrp3-activated bone marrow dendritic cells play antileukemic roles via il-1beta\/th1\/ifn-gamma in acute myeloid leukemia","volume":"520","author":"Liu","year":"2021","journal-title":"Cancer Lett."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0445","doi-asserted-by":"crossref","first-page":"e38222","DOI":"10.1128\/iai.00382-22","article-title":"Nlrp3 plays a key role in antihelminth immunity in the enteral and parenteral stages of trichinella spiralis-infected mice","volume":"91","author":"Pan","year":"2023","journal-title":"Infect. Immun."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0450","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.4049\/jimmunol.1500542","article-title":"The inflammatory caspases-1 and -11 mediate the pathogenesis of dermatitis in sharpin-deficient mice","volume":"195","author":"Douglas","year":"2015","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0455","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41590-024-01788-y","article-title":"Anaphylactic degranulation by mast cells requires the mobilization of inflammasome components","volume":"25","author":"Mencarelli","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.113696_b0460","doi-asserted-by":"crossref","first-page":"8878153","DOI":"10.1155\/2021\/8878153","article-title":"Cicadidae periostracum attenuates atopic dermatitis symptoms and pathology via the regulation of nlrp3 inflammasome activation","volume":"2021","author":"Park","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0465","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jaci.2021.09.014","article-title":"Il-33 signaling in sensory neurons promotes dry skin itch","volume":"149","author":"Trier","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113696_b0470","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41419-021-04159-9","article-title":"A novel function of nlrp3 independent of inflammasome as a key transcription factor of il-33 in epithelial cells of atopic dermatitis","volume":"12","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0475","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2016.05.046","article-title":"Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (pde4) inhibitor for the topical treatment of atopic dermatitis (ad) in children and adults","volume":"75","author":"Paller","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.intimp.2024.113696_b0480","doi-asserted-by":"crossref","unstructured":"E. Guttman-Yassky, R. Bissonnette, B. Ungar, M. Suarez-Farinas, M. Ardeleanu, H. Esaki, M. Suprun, Y. Estrada, H. Xu, X. Peng, J.I. Silverberg, A. Menter, J.G. Krueger, R. Zhang, U. Chaudhry, B. Swanson, N. Graham, G. Pirozzi, G.D. Yancopoulos, H.J. D, Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis, J Allergy Clin Immunol 143(1) (2019) 155-172, doi: 10.1016\/j.jaci.2018.08.022.","DOI":"10.1016\/j.jaci.2018.08.022"},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0485","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jaad.2018.01.016","article-title":"Efficacy and safety of fezakinumab (an il-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: a randomized, double-blind, phase 2a trial","volume":"78","author":"Guttman-Yassky","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"issue":"515","key":"10.1016\/j.intimp.2024.113696_b0490","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2945","article-title":"Proof-of-concept clinical trial of etokimab shows a key role for il-33 in atopic dermatitis pathogenesis","volume":"11","author":"Chen","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.intimp.2024.113696_b0495","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","article-title":"Structural mechanisms of nlrp3 inflammasome assembly and activation","volume":"41","author":"Fu","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0500","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The nlrp3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"6372","key":"10.1016\/j.intimp.2024.113696_b0505","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/356768a0","article-title":"A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes","volume":"356","author":"Thornberry","year":"1992","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0510","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.20172222","article-title":"Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity","volume":"215","author":"Boucher","year":"2018","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0515","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.cell.2014.02.008","article-title":"Unified polymerization mechanism for the assembly of asc-dependent inflammasomes","volume":"156","author":"Lu","year":"2014","journal-title":"Cell"},{"issue":"7081","key":"10.1016\/j.intimp.2024.113696_b0520","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nature04515","article-title":"Cryopyrin activates the inflammasome in response to toxins and atp","volume":"440","author":"Mariathasan","year":"2006","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.intimp.2024.113696_b0525","doi-asserted-by":"crossref","first-page":"20574","DOI":"10.1074\/jbc.M109.023689","article-title":"Fungal zymosan and mannan activate the cryopyrin inflammasome","volume":"284","author":"Lamkanfi","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"7444","key":"10.1016\/j.intimp.2024.113696_b0530","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces il-1beta through hif-1alpha","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2024.113696_b0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109558","article-title":"Increased mitochondrial fission induces nlrp3\/cgas-sting mediated pro-inflammatory pathways and apoptosis in uvb-irradiated immortalized human keratinocyte hacat cells","volume":"738","author":"Li","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0540","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The nlrp3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem. Sci"},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0545","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","article-title":"K(+) efflux is the common trigger of nlrp3 inflammasome activation by bacterial toxins and particulate matter","volume":"38","author":"Munoz-Planillo","year":"2013","journal-title":"Immunity"},{"issue":"38","key":"10.1016\/j.intimp.2024.113696_b0550","doi-asserted-by":"crossref","first-page":"eabf4468","DOI":"10.1126\/sciadv.abf4468","article-title":"Sensing low intracellular potassium by nlrp3 results in a stable open structure that promotes inflammasome activation","volume":"7","author":"Tapia-Abellan","year":"2021","journal-title":"Sci. Adv."},{"issue":"7590","key":"10.1016\/j.intimp.2024.113696_b0555","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/nature16959","article-title":"Nek7 is an essential mediator of nlrp3 activation downstream of potassium efflux","volume":"530","author":"He","year":"2016","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.intimp.2024.113696_b0560","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the nlrp3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0565","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","article-title":"Oxidized dna fragments exit mitochondria via mptp- and vdac-dependent channels to activate nlrp3 inflammasome and interferon signaling","volume":"55","author":"Xian","year":"2022","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0570","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial dna activates the nlrp3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"issue":"7329","key":"10.1016\/j.intimp.2024.113696_b0575","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in nlrp3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.intimp.2024.113696_b0580","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the nalp3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2024.113696_b0585","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.jid.2023.03.1680","article-title":"Excessive production of hydrogen peroxide in mitochondria contributes to atopic dermatitis","volume":"143","author":"Minzaghi","year":"2023","journal-title":"J, Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0590","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8488-5","article-title":"Mediators of chronic pruritus in atopic dermatitis: getting the itch out?","volume":"51","author":"Mollanazar","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7575","key":"10.1016\/j.intimp.2024.113696_b0595","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of gsdmd by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"7521","key":"10.1016\/j.intimp.2024.113696_b0600","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory caspases are innate immune receptors for intracellular lps","volume":"514","author":"Shi","year":"2014","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0605","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cell.2016.09.012","article-title":"Irgb10 liberates bacterial ligands for sensing by the aim2 and caspase-11-nlrp3 inflammasomes","volume":"167","author":"Man","year":"2016","journal-title":"Cell"},{"issue":"7500","key":"10.1016\/j.intimp.2024.113696_b0610","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature13157","article-title":"Caspase-11 activation requires lysis of pathogen-containing vacuoles by ifn-induced gtpases","volume":"509","author":"Meunier","year":"2014","journal-title":"Nature"},{"issue":"7371","key":"10.1016\/j.intimp.2024.113696_b0615","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0620","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1038\/s41467-020-16889-z","article-title":"Human gbp1 binds lps to initiate assembly of a caspase-4 activating platform on cytosolic bacteria","volume":"11","author":"Santos","year":"2020","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.intimp.2024.113696_b0625","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/exd.14412","article-title":"Mdivi-1 alleviates atopic dermatitis through the inhibition of nlrp3 inflammasome","volume":"30","author":"Li","year":"2021","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.intimp.2024.113696_b0630","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24097720","article-title":"The anti-atopic dermatitis effects of mentha arvensis essential oil are involved in the inhibition of the nlrp3 inflammasome in dncb-challenged atopic dermatitis balb\/c mice","volume":"24","author":"Kim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"10.1016\/j.intimp.2024.113696_b0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241512367","article-title":"Coffea arabica extract attenuates atopic dermatitis-like skin lesions by regulating nlrp3 inflammasome expression and skin barrier functions","volume":"24","author":"Chang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2024.113696_b0640","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/1440-1681.13809","article-title":"Esculentoside a ameliorates dncb-induced atopic dermatitis by suppressing the ros-nlrp3 axis via activating the nrf2 pathway","volume":"50","author":"Liu","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0645","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41589-019-0278-6","article-title":"Mcc950 closes the active conformation of nlrp3 to an inactive state","volume":"15","author":"Tapia-Abellan","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.intimp.2024.113696_b0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of mcc950, a specific inhibitor of nlrp3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2024.113696_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175931","article-title":"Research progress of nlrp3 inflammasome and its inhibitors with aging diseases","volume":"957","author":"Yuan","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0660","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0091-6749(76)90054-3","article-title":"Inhibition of hypersensitivity reactions by a new drug, n(3',4'-dimethoxycinnamoyl) anthranilic acid (n-5')","volume":"57","author":"Koda","year":"1976","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0665","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets nlrp3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2024.113696_b0670","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.phrs.2014.10.009","article-title":"Tranilast: a review of its therapeutic applications","volume":"91","author":"Darakhshan","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.intimp.2024.113696_b0675","doi-asserted-by":"crossref","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"Olt1177, a beta-sulfonyl nitrile compound, safe in humans, inhibits the nlrp3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0680","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s15010-022-01904-w","article-title":"Dfv890: a new oral nlrp3 inhibitor-tested in an early phase 2a randomised clinical trial in patients with covid-19 pneumonia and impaired respiratory function","volume":"51","author":"Madurka","year":"2023","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0685","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","article-title":"Strategies for targeting the nlrp3 inflammasome in the clinical and preclinical space","volume":"64","author":"Schwaid","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2024.113696_b0690","unstructured":"F. Hofmann-La Roche Ltd. Roche Group product development portfolio, 2024. <http:\/\/www.inflazome.com\/> (Accessed 21 May 2024)."},{"key":"10.1016\/j.intimp.2024.113696_b0695","unstructured":"Ventyx Biosciences, Inc. Ventyx Biosciences announces positive topline phase 1 data for its peripheral NLRP3 inhibitor VTX2735. 2024. https:\/\/ir.ventyxbio.com\/node\/7071\/html, 2024. (ACCESSED 9 Jun 2024)."},{"key":"10.1016\/j.intimp.2024.113696_b0700","doi-asserted-by":"crossref","unstructured":"X. Jin, D. Liu, X. Zhou, X. Luo, Q. Huang, Y. Huang, Entrectinib inhibits nlrp3 inflammasome and inflammatory diseases by directly targeting nek7, Cell Rep. Med. 4(12) (2023) 101310, doi: 10.1016\/j.xcrm.2023.101310.","DOI":"10.1016\/j.xcrm.2023.101310"},{"key":"10.1016\/j.intimp.2024.113696_b0705","doi-asserted-by":"crossref","first-page":"1307739","DOI":"10.3389\/fimmu.2023.1307739","article-title":"A novel nlrp3 inhibitor as a therapeutic agent against monosodium urate-induced gout","volume":"14","author":"Park","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0710","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41401-023-01212-5","article-title":"Britannin as a novel nlrp3 inhibitor, suppresses inflammasome activation in macrophages and alleviates nlrp3-related diseases in mice","volume":"45","author":"Shao","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0715","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-020-01826-0","article-title":"Ic100: a novel anti-asc monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis","volume":"17","author":"Desu","year":"2020","journal-title":"J. Neuroinflam."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0720","doi-asserted-by":"crossref","first-page":"e15415","DOI":"10.15252\/emmm.202115415","article-title":"Nanobodies dismantle post-pyroptotic asc specks and counteract inflammation in vivo","volume":"14","author":"Bertheloot","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.intimp.2024.113696_b0725","doi-asserted-by":"crossref","unstructured":"C.D. Ellis, K.A. Oppong, M.C. Laufersweiler, S.V. O'Neil, D.L. Soper, Y. Wang, J.A. Wos, A.N. Fancher, W. Lu, M.K. Suchanek, R.L. Wang, De B, T.J. Demuth, Synthesis and evaluation of thiazepines as interleukin-1beta converting enzyme (ice) inhibitors, Bioorg Med Chem Lett 16(18) (2006) 4728-4732, doi: 10.1016\/j.bmcl.2006.07.016.","DOI":"10.1016\/j.bmcl.2006.07.016"},{"key":"10.1016\/j.intimp.2024.113696_b0730","first-page":"3","article-title":"Inflammasomes: caspase-1-activating platforms with critical roles in host defense","volume":"2","author":"Vande","year":"2011","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113696_b0735","first-page":"111","article-title":"Effects and mechanisms of potent caspase-1 inhibitor vx765 treatment on collagen-induced arthritis in mice","volume":"34","author":"Zhang","year":"2016","journal-title":"Clin. Exp. Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0740","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.4049\/jimmunol.175.4.2630","article-title":"Il-converting enzyme\/caspase-1 inhibitor vx-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients","volume":"175","author":"Stack","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113696_b0745","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115861","article-title":"Interleukin-1beta converting enzyme (ice): a comprehensive review on discovery and development of caspase-1 inhibitors","volume":"261","author":"Modi","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0750","first-page":"337","article-title":"Topical corticosteroids: choice and application","volume":"103","author":"Stacey","year":"2021","journal-title":"Am. Fam. Physician"},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0755","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1525-1470.1992.tb00638.x","article-title":"Atopic dermatitis: studies of skin permeability and effectiveness of topical puva treatment","volume":"9","author":"Ogawa","year":"1992","journal-title":"Pediatr. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0760","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1046\/j.1365-4362.2001.01161.x","article-title":"Azone enhances clinical effectiveness of an optimized formulation of triamcinolone acetonide in atopic dermatitis","volume":"40","author":"Cato","year":"2001","journal-title":"Int. J. Dermatol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0765","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00403-019-02017-5","article-title":"Effect of propylene glycol on the skin penetration of drugs","volume":"312","author":"Carrer","year":"2020","journal-title":"Arch. Dermatol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0770","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1080\/03007995.2024.2340734","article-title":"The use of essential oils in atopic dermatitis: a review","volume":"40","author":"Azhari","year":"2024","journal-title":"Curr. Med. Res. Opin."},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0775","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020071","article-title":"Hydrogels for atopic dermatitis and wound management: a superior drug delivery vehicle","volume":"10","author":"Harrison","year":"2018","journal-title":"Pharmaceutics"},{"issue":"32","key":"10.1016\/j.intimp.2024.113696_b0780","doi-asserted-by":"crossref","first-page":"36331","DOI":"10.1021\/acsami.2c07135","article-title":"Skin penetration enhancer-incorporated lipid nanovesicles (spe-lnv) for skin brightening and wrinkle treatment","volume":"14","author":"Lee","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.intimp.2024.113696_b0785","doi-asserted-by":"crossref","unstructured":"J. Chen, H. Ren, P. Zhou, S. Zheng, Du B, X. Liu, F. Xiao, Microneedle-mediated drug delivery for cutaneous diseases, Front Bioeng Biotechnol 10 (2022) 1032041, doi: 10.3389\/fbioe.2022.1032041.","DOI":"10.3389\/fbioe.2022.1032041"},{"issue":"7","key":"10.1016\/j.intimp.2024.113696_b0790","doi-asserted-by":"crossref","first-page":"e2001691","DOI":"10.1002\/adhm.202001691","article-title":"High-dose steroid dissolving microneedle for relieving atopic dermatitis","volume":"10","author":"Jang","year":"2021","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"10.1016\/j.intimp.2024.113696_b0795","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41423-021-00683-y","article-title":"Rrx-001 ameliorates inflammatory diseases by acting as a potent covalent nlrp3 inhibitor","volume":"18","author":"Chen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0800","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective nlrp3 inflammasome inhibitor, for treatment of gout flares: an open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kluck","year":"2020","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"10.1016\/j.intimp.2024.113696_b0805","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/cpdd.1162","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral nlrp3 inflammasome inhibitor zyil1: first-in-human phase 1 studies (single ascending dose and multiple ascending dose)","volume":"12","author":"Parmar","year":"2023","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"21","key":"10.1016\/j.intimp.2024.113696_b0810","doi-asserted-by":"crossref","first-page":"14897","DOI":"10.1021\/acs.jmedchem.3c01398","article-title":"Discovery of clinical candidate nt-0796, a brain-penetrant and highly potent nlrp3 inflammasome inhibitor for neuroinflammatory disorders","volume":"66","author":"Harrison","year":"2023","journal-title":"J. Med. Chem."},{"issue":"28","key":"10.1016\/j.intimp.2024.113696_b0815","doi-asserted-by":"crossref","first-page":"e2301577","DOI":"10.1002\/adhm.202301577","article-title":"Targeted delivery of the pan-inflammasome inhibitor mm01 as an alternative approach to acute lung injury therapy","volume":"12","author":"Garcia-Fernandez","year":"2023","journal-title":"Adv. Healthc. Mater."},{"issue":"Pt 4","key":"10.1016\/j.intimp.2024.113696_b0820","article-title":"Therapeutic effects of chamomile volatile oil nanoemulsion\/bletilla striata polysaccharides gels on atopic dermatitis","volume":"277","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.intimp.2024.113696_b0825","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.jaad.2021.04.085","article-title":"Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies","volume":"85","author":"Papp","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"10.1016\/j.intimp.2024.113696_b0830","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2174\/1574888X18666230418121053","article-title":"The current status and future direction of extracellular nano-vesicles in the alleviation of skin disorders","volume":"19","author":"Ghorbani","year":"2024","journal-title":"Curr. Stem Cell Res. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2024.113696_b0835","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.7150\/ijbs.92897","article-title":"Exosomes: the emerging mechanisms and potential clinical applications in dermatology","volume":"20","author":"Yu","year":"2024","journal-title":"Int. J. Biol. Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924022185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:39:15Z","timestamp":1789645155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924022185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":167,"alternative-id":["S1567576924022185"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113696","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing NLRP3 inflammasome activation: Therapeutic atrategy and challenges in atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113696"}}